- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
TRITON / ALERIS
M.9493
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Disclaimer :
The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.
SECTION 1.2
Description of the concentration
1.The notified concentration involves the proposed acquisition by the Triton group (“Triton”, Luxembourg) of sole control of Aleris Healthcare AB and Aleris Imaging AB (“Aleris”, Sweden) (the “Proposed Transaction”), by way of a purchase of shares, within the meaning of Article 3(1)(b) of the EU Merger Regulation.
2.Triton is an investment firm that invests primarily in German-speaking countries, the Nordic countries, the Benelux region, France, Italy, Spain and the United Kingdom.
3.Aleris is a Scandinavian private provider of specialty healthcare with a versatile offering of specialist care and diagnostic services. Through approx. 100 facilities, Aleris aims to provide a person-oriented and seamless healthcare journey for all individuals seeking care – either physically or through its digital offering.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.